Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: A possible cause of false positive results in molecular-based diagnosis of thyroid carcinomas

Citation
T. Takano et al., Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: A possible cause of false positive results in molecular-based diagnosis of thyroid carcinomas, J CLIN END, 85(2), 2000, pp. 765-768
Citations number
22
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
ISSN journal
0021972X → ACNP
Volume
85
Issue
2
Year of publication
2000
Pages
765 - 768
Database
ISI
SICI code
0021-972X(200002)85:2<765:EOOFMR>2.0.ZU;2-U
Abstract
Oncofetal fibronectin (onfFN) messenger ribonucleic acid (mRNA) is abundant ly expressed in thyroid papillary and anaplastic carcinomas. These carcinom as can be preoperatively diagnosed by the detection of onfFN mRNA. in fine needle aspiration biopsies (FNABs). However, previous reports have noted th at the expression of onfFN mRNA was observed in 3.7% of the FNABs that were diagnosed as negative cytology. To clarify this discrepancy, we examined t he expression of onfFN mRNA in fibroblasts in the thyroid. By RT-PCR and re al-time quantitative RT-PCR analyses, we detected a high copy number of onf FN mRNA in cultured fibroblasts obtained from the normal thyroid tissues di ssected surgically. Thus, we conclude that the contaminated fibroblasts in FNABs due to tumor necrosis or acute or chronic inflammation may be a cause of false positive results in molecular-based diagnosis of thyroid carcinom as.